Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+7.34%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
9.5%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$125M |
| 2 |
Apple
AAPL
|
+$107M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
FedEx
FDX
|
+$95.2M |
| 5 |
Fidelity National Information Services
FIS
|
+$90M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$100M |
| 2 |
Cigna
CI
|
+$97.2M |
| 3 |
Phillips 66
PSX
|
+$84.3M |
| 4 |
Gilead Sciences
GILD
|
+$80.1M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| 1 | Technology | 26.39% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
451
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.64M | 0.02% |
95,726
-22,247
| -19% | -$845K |
|
|
CELL
452
DELISTED
PhenomeX Inc. Common Stock
CELL
| $3.61M | 0.02% |
1,347,074
-37,980
| -3% | -$102K |
|
453
Marcus & Millichap
MMI
$1.27B
| $3.53M | 0.02% |
102,426
-26,852
| -21% | -$925K |
|
454
Capri Holdings
CPRI
$2.54B
| $3.5M | 0.02% |
61,048
+7,921
| +15% | +$454K |
|
455
Harmonic Inc
HLIT
$1.13B
| $3.5M | 0.02% |
+267,020
| New | +$3.5M |
|
456
Perrigo
PRGO
$3.07B
| $3.49M | 0.02% |
102,336
-23,109
| -18% | -$788K |
|
457
Preferred Bank
PFBC
$1.17B
| $3.45M | 0.02% |
46,269
+3,282
| +8% | +$245K |
|
458
Affiliated Managers Group
AMG
$6.59B
| $3.44M | 0.02% |
21,717
-1,322
| -6% | -$209K |
|
459
Privia Health
PRVA
$2.88B
| $3.43M | 0.02% |
151,010
-29,078
| -16% | -$660K |
|
460
TruBridge
TBRG
$299M
| $3.42M | 0.02% |
125,718
+375
| +0.3% | +$10.2K |
|
461
Mirum Pharmaceuticals
MIRM
$3.9B
| $3.41M | 0.02% |
175,122
-20,397
| -10% | -$398K |
|
462
Amneal Pharmaceuticals
AMRX
$3.11B
| $3.39M | 0.02% |
1,702,035
+259,725
| +18% | +$517K |
|
|
NGM
463
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.38M | 0.02% |
673,164
+604,515
| +881% | +$3.03M |
|
464
Dyne Therapeutics
DYN
$1.88B
| $3.36M | 0.02% |
289,993
+68,945
| +31% | +$799K |
|
465
Enphase Energy
ENPH
$4.96B
| $3.36M | 0.02% |
12,673
+8,287
| +189% | +$2.2M |
|
466
Astec Industries
ASTE
$1.05B
| $3.35M | 0.02% |
82,370
+3,681
| +5% | +$150K |
|
467
Mercado Libre
MELI
$120B
| $3.33M | 0.02% |
3,930
+1,388
| +55% | +$1.17M |
|
468
First Commonwealth Financial
FCF
$1.83B
| $3.32M | 0.02% |
237,565
-77,585
| -25% | -$1.08M |
|
469
HF Sinclair
DINO
$9.81B
| $3.24M | 0.02% |
62,517
+4,007
| +7% | +$208K |
|
470
Heritage Financial
HFWA
$844M
| $3.22M | 0.02% |
104,983
+19,930
| +23% | +$611K |
|
471
Gen Digital
GEN
$18.1B
| $3.21M | 0.02% |
149,697
-225,280
| -60% | -$4.83M |
|
472
Atara Biotherapeutics
ATRA
$83.9M
| $3.16M | 0.02% |
38,531
+24,318
| +171% | +$1.99M |
|
473
Herc Holdings
HRI
$4.44B
| $3.13M | 0.02% |
23,815
-2,926
| -11% | -$385K |
|
474
Protagonist Therapeutics
PTGX
$3.63B
| $3.1M | 0.02% |
284,115
+29,775
| +12% | +$325K |
|
475
Comfort Systems
FIX
$25B
| $3.05M | 0.02% |
+26,534
| New | +$3.05M |
|